Endoluxe Patents – Insights & Stats (Updated 2023)

Endoluxe has a total of 10 patents globally, out of which 3 have been granted. Of these 10 patents, more than 80% patents are active. United States of America is where Endoluxe has filed the maximum number of patents. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Endoluxe.

Endoluxe was founded in the year 2013. The Company develops, manufactures, sells and markets minimally invasive treatments for vascular diseases. The Company’s products include the Powerlink System, a catheter-based endoluminal stent graft that treats abdominal aortic aneurysms.

Do read about some of the most popular patents of Endoluxe which have been covered by us in this article and also you can find Endoluxe patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Endoluxe patent portfolio.

How many patents does the founder and the CEO of Endoluxe have?

The founders Neal Patel has 10 patents and Philip Zhao has 10 patents and CEO Devon Bream has 2 patents.

How many patents does Endoluxe have?

Endoluxe has a total of 10 patents globally. These patents belong to 3 unique patent families. Out of 10 patents, 8 patents are active.

How Many Patents did Endoluxe File Every Year?

Endoluxe Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantEndoluxe Applications FiledEndoluxe Patents Granted
202331
20221
202011
201821
20171
20152

How many Endoluxe patents are Alive/Dead?

Endoluxe Patent Portfolio

How Many Patents did Endoluxe File in Different Countries?

All the Patents were filed by Endoluxe in the United States of America.

Where are Research Centres of Endoluxe Patents Located?

The Research Centre for all the Endoluxe patents is the United States of America.

What Percentage of Endoluxe US Patent Applications were Granted?

Endoluxe (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Endoluxe patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Endoluxe?

Law FirmTotal ApplicationsSuccess Rate
Dentons Us Llp Joel Bock2100.00%
Dentons Us Llp Roman Tsibulevskiy20%

List of Endoluxe Patents

Endoluxe PatentsTitle
US11723514B2System And Methods For Endoscopic Imaging
US10772488B2System And Methods For Endoscopic Imaging
US10130244B2Encasement Platform For Smartdevice For Attachment To Endoscope
US20230380661A1System And Methods For Endoscopic Imaging
US20230248211A1Systems, Apparatuses, And Methods For Endoscopy
US20230218146A1Systems, Apparatuses, And Methods For Endoscopy
US20190133424A1Encasement Platform For Smartdevice For Attachment To Endoscope
WO2023133339A1Systems, Apparatuses, And Methods For Endoscopy
WO2019094235A1System And Methods For Endoscopic Imaging
WO2015191954A1Encasement Platform For Smartdevice For Attachment To Endoscope

What are Endoluxe key innovation segments?

What Technologies are Covered by Endoluxe?

The chart below distributes patents filed by Endoluxe in different countries on the basis of the technology protected in patents. It also represents the markets where Endoluxe thinks it’s important to protect particular technology inventions.

R&D Focus: How has Endoluxe search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Endoluxe?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.